Cat. No. | Product name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T13156L | TG 100572 Hydrochloride | 867331-64-4 | 98% |
|
TG 100572 Hydrochloride is a inhibitor of multi-targeted kinase which inhibits receptor tyrosine kinases and Src kinases(IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1... | ||||
T8544 | Masitinib mesylate | 1048007-93-7 | 98% |
|
Masitinib mesylate (AB-1010 mesylate) is a selective and orally bioavailable c-Kit inhibitor (IC50 of 200 nM,540/800 nM,510 nM for human recombinant c-Kit;PDGFRα... | ||||
T4320 | Flumatinib | 895519-90-1 | 98% |
|
Flumatinib (HHGV678) is an orally bioavailable tyrosine kinase inhibitor flumatinib, with potential antineoplastic activity. | ||||
T76761 | Olaratumab | 1024603-93-7 | 98% |
Olaratumab
|
Olaratumab(IMC-3G3) is a human monoclonal IgG1 antibody against platelet-derived growth factor receptor alpha (PDGFRα), which has antitumor effects and can be us... | ||||
T8900 | Seralutinib | 1619931-27-9 | 98% |
|
Seralutinib (GB002) is an inhibitor of inhaled PDGFRα and PDGFRβ. It is used in the study for pulmonary arterial hypertension. | ||||
T16947 | SU16f | 251356-45-3 | 98% |
|
SU16f (3-substituted indolin-2-one 16f) is a potent and selective PDGFRβ inhibitor (IC50s: 10 nM, 140 nM, 2.29 μM for PDGFRβ, PDGFR1, PDGFR2, respectively). Neut... | ||||
T1895 | SKLB 610 | 1125780-41-7 | 98% |
|
SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2, and PDGFR at a rate of 97%, 65%, and 55%, respectively, a... |